Skip to content
Search

Latest Stories

Gophr data reveals growing ‘Pharmacy Deserts’ amid surging closures across England

Gophr data reveals growing ‘Pharmacy Deserts’ amid surging closures across England

Pharmacy deserts are most prevalent in the South East, with 6,024 people per pharmacy

Online pharmacy delivery partner Gophr has released new data showing a further drop in pharmacy numbers in England, resulting in a phenomenon they call 'Pharmacy Deserts'.

Gophr highlighted that a significant portion of the population now lives in 'pharmacy deserts,' referring to the situation where an increasing number of urban residents struggle to access a shrinking number of pharmacies.


For the second consecutive year, Gophr has analysed the data for its 'Prescription For Pressure' initiative.

The analysis showed that in 2023, pharmacists dispensed 1.18 billion prescriptions across England, marking an increase of 137 million compared to 2022.

The average number of prescriptions per pharmacy stands at 103,380, which equates to 283 a day.

As calculated by Gophr’s data experts, pharmacy numbers decreased from 11,522 in 2022 to 11,414 in 2023, reflecting a decline of 108 compared to the previous year's 'Prescription For Pressure'.

Gophr’s data also showed that pharmacy deserts are most prominent in the South East (6,024 people per pharmacy), the East of England (5,327), the South West (5,284), and the Midlands (4,975).

London, which ranked high last year, fell out of the top four, with 4,759 people per pharmacy.

Gophr's analysis of supermarket data also revealed that retailers like ASDA, Tesco, and Sainsbury’s have seen more and more in-store pharmacies shut down in recent years.

A notable example is Sainsbury's closure of all 237 in-store Lloyds pharmacies in June 2023.

Graham Smith, Strategic Account Director at Gophr, commented: “The second year of data from our “Prescription for Pressure” initiative shows that the pressures on pharmacies continue to grow.

“More prescriptions, more patients, more responsibilities but fewer pharmacies does not make for pretty reading and this new analysis really brings it home.”

He stated that the sector needs to reconsider how it serves its patients, noting that the current solutions provided by in-house pharmacy delivery teams are proving “costly, time-consuming, and ultimately a distraction from clinical focus.”

Additionally, the research uncovered growing pressures within the industry, exacerbated by the implementation of the 'Pharmacy First' initiative.

The Pharmacy First scheme, which allows patients to be referred to a community pharmacy for a minor illness or an urgent repeat medicine supply, has created an even greater workload for already overstretched pharmacists.

The increasing elderly population is believed to be driving the demand for pharmacy services. Across England and Wales, people aged 65 and over now account for nearly 20 per cent of the population, according to Gophr.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less